[ESPR] QoQ Quarter Result on 31-Mar-2001 [#Q1]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
30-Mar-2001
Financial Year
2001
Quarter
31-Mar-2001 [#Q1]
Profit Trend
QoQ- -7.48%
YoY- -27.45%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
31/12/01 30/09/01 30/06/01 31/03/01 31/12/00 30/09/00 30/06/00 CAGR
Revenue 0 0 1 1 1 1 1 -
PBT -6,344 -6,281 -6,325 -5,981 -6,803 -11,693 -7,371 -9.49%
Tax -112 736 -454 -976 1,233 3,556 -308 -48.95%
NP -6,344 -6,281 -6,325 -5,981 -5,565 -10,804 -6,514 -1.74%
Tax Rate - - - - - - - -
Total Cost 6,344 6,281 6,326 5,982 5,566 10,805 6,515 -1.75%
Ratio Analysis
31/12/01 30/09/01 30/06/01 31/03/01 31/12/00 30/09/00 30/06/00 CAGR
NP Margin 0.00 0.00 -632,500.00 -598,100.00 -556,500.00 -1,080,400.00 -651,400.00 -
Per Share
31/12/01 30/09/01 30/06/01 31/03/01 31/12/00 30/09/00 30/06/00 CAGR
EPS -1.57 -1.56 -1.70 -1.61 -2.65 -5.14 -20.60 -81.93%
EPS Diluted -1.57 -1.56 -1.70 -1.61 -2.65 -5.14 -20.60 -81.93%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.